Immix Biopharma (IMMX) Other Non-Current Liabilities (2020 - 2021)
Immix Biopharma (IMMX) reported Other Non-Current Liabilities of $23.41 million for Q4 2021, compared with $575,000 a year earlier.
Powered by 
Analysis
Immix Biopharma (IMMX) Other Non-Current Liabilities (2020 - 2021) Analysis & Trends
- By year, Other Non-Current Liabilities came in at $575,000 in FY2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,170.42 Bn | 1,139.01 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 648.22 Bn | 568.08 Bn | 17.30 Bn |
| 3 | AbbVie | 504.43 Bn | 477.54 Bn | 12.70 Bn |
| 4 | Merck | 369.14 Bn | 323.52 Bn | 12.21 Bn |
| 5 | Novartis Ag | 303.29 Bn | 267.28 Bn | 11.24 Bn |
| 6 | Astrazeneca | 268.21 Bn | 241.90 Bn | 12.86 Bn |
| 7 | Amgen | 242.56 Bn | 197.96 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.91 Bn | 169.11 Bn | 6.22 Bn |
| 9 | Pfizer | 173.28 Bn | 119.92 Bn | 10.94 Bn |
| 10 | Immix Biopharma | 529.94 Mn | 297.84 Mn | - |
API Access
Immix Biopharma Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=IMMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "IMMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=IMMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();